
Company valuation, historical trends, and peer comparisons.
According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 963.26M. This represents a change of 68.03% compared to the average of 573.28M of the last 4 quarters.
The mean historical Enterprise Value of Vor Biopharma Inc. over the last ten years is 431.88M. The current 963.26M Enterprise Value has changed 123.04% with respect to the historical average. Over the past ten years (40 quarters), VOR's Enterprise Value was at its highest in in the September 2026 quarter at 1.06B. The Enterprise Value was at its lowest in in the December 2025 quarter at -264361992.72.
Average
431.88M
Median
230.01M
Minimum
-264361992.72
Maximum
1.39B
Discovering the peaks and valleys of Vor Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 542.05%
Maximum Annual Enterprise Value = 1.39B
Minimum Annual Increase = -1111.17%
Minimum Annual Enterprise Value = -264361992.72
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -264361992.72 | -1111.17% |
| 2024 | 26.14M | -83.19% |
| 2023 | 155.48M | -36.34% |
| 2022 | 244.22M | -26.03% |
| 2021 | 330.18M | -75.76% |
| 2020 | 1.36B | -1.70% |
| 2019 | 1.39B | 542.05% |
The current Enterprise Value of Vor Biopharma Inc. (VOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27578592.44
5-year avg
98.33M
10-year avg
431.88M
Vor Biopharma Inc.’s Enterprise Value is greater than Sana Biotechnology, Inc. (749.35M), less than CRISPR Therapeutics AG (5.41B), greater than Rocket Pharmaceuticals, Inc. (67.59M), greater than Nkarta, Inc. (158.88M), greater than Fate Therapeutics, Inc. (280.44M), greater than Century Therapeutics, Inc. (255.69M), greater than Autolus Therapeutics plc (296.69M), greater than Editas Medicine, Inc. (242.99M), less than Intellia Therapeutics, Inc. (1.66B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 749.35M | $732.69M | |
| 5.41B | $4.92B | |
| 67.59M | $267.30M | |
| 158.88M | $110.30M | |
| 280.44M | $237.20M | |
| 255.69M | $270.71M | |
| 296.69M | $384.60M | |
| 242.99M | $409.29M | |
| 1.66B | $1.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vor Biopharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vor Biopharma Inc. (VOR)?
What is the 3-year average Enterprise Value for Vor Biopharma Inc. (VOR)?
What is the 5-year average Enterprise Value for Vor Biopharma Inc. (VOR)?
How does the current Enterprise Value for Vor Biopharma Inc. (VOR) compare to its historical average?